1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 24 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1999Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationshipsDyer, K.; Foster, D.; White, J.; Somogyi, A.; Menelaou, A.; Bochner, F.
2008Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjectsLa Vincente, S.; White, J.; Somogyi, A.; Bochner, F.; Chapleo, C.
2004CYP3A4 mediates dextropropoxyphene N-demethylation to nordextropropoxyphene: human in vitro and in vivo studies and lack of CYP2D6 involvementSomogyi, A.; Menelaou, A.; Fullston, S.
2001The relationship between mood state and plasma methadone concentration in maintenance patientsDyer, K.; White, J.; Foster, D.; Bochner, F.; Menelaou, A.; Somogyi, A.
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
1999Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and dark Agouti RatsMalpass, A.; White, J.; Irvine, R.; Somogyi, A.; Bochner, F.
1996The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.Capon, D.; Bochner, F.; Kerry, N.; Mikus, G.; Danz, C.; Somogyi, A.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2000Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsFoster, D.; Somogyi, A.; Dyer, K.; White, J.; Bochner, F.
1999Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.Coller, J.; Somogyi, A.; Bochner, F.

Discover